Position in ALNY
as of Mar 31, 2026
· filed Apr 6, 2026
Position Value
$328,884
-$26,217 QoQ
Shares Held
994
+11.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GAMMA Investing LLC holds $15,891,706 across 254 Biotechnology names. ALNY ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,592 | $2,943,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,507 | $1,937,008 | |
| 3 | MRNA |
Moderna, Inc.
|
15,297 | $777,087 | |
| 4 | INCY |
Incyte Corp
|
7,261 | $683,405 | |
| 5 | TECH |
BIO-TECHNE Corp
|
10,065 | $525,996 | |
| 6 | EXEL |
Exelixis, Inc.
|
9,582 | $410,971 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
12,465 | $345,280 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
994 | $328,884 |
All Filings in ALNY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $328,884 | 994 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $355,101 | 893 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $375,288 | 823 | Shares | Defined | 2025-10-02 | |
| 2025-06-30 | $236,741 | 726 | Shares | Defined | 2025-07-14 | |
| 2025-03-31 | $166,332 | 616 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $126,832 | 539 | Shares | Defined | 2025-01-03 | |
| 2024-09-30 | $152,366 | 554 | Shares | Defined | 2024-10-07 | |
| 2024-06-30 | $101,088 | 416 | Shares | Defined | 2024-07-02 | |
| 2024-03-31 | $31,533 | 211 | Shares | Defined | 2024-04-05 | |
| 2023-12-31 | $51,680 | 270 | Shares | Defined | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||